Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9618 USD | -0.09% | +19.32% | -52.85% |
Apr. 30 | Gritstone Bio, Inc. Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA Vaccine at ESCMID Global 2024 | CI |
Apr. 29 | Gritstone Bio, Inc. Announces Board Changes | CI |
Evolution of the average Target Price on Gritstone bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Gritstone bio, Inc.
B. Riley | |
Piper Sandler | |
HC Wainwright | |
Goldman Sachs | |
BTIG | |
Baird |
EPS Revisions
- Stock Market
- Equities
- GRTS Stock
- Consensus Gritstone bio, Inc.